Asthma in pregnancy

Steven L. Clark; Marilynn C. Frederiksen; Mark M. Jacobs; Ralph Kauffman; Allan T. Luskin; Donald McNellis; Debra Myers; Harold S. Nelson; Michael Schatz; Anthony R. Scialli; Robert A. Wise; Sydney R. Parker; Virginia S. Taggert

Asthma in pregnancy

Steven L. Clark, Marilynn C. Frederiksen, Mark M. Jacobs, Ralph Kauffman, Allan T. Luskin, Donald McNellis, Debra Myers, Harold S. Nelson, Michael Schatz, Anthony R. Scialli, Robert A. Wise, Sydney R. Parker, Virginia S. Taggert

Research output: Contribution to journal › Article › peer-review

59 Scopus citations

Abstract

This manuscript is a summary of a comprehensive report dealing with asthma and pregnancy issued by the working group on Asthma and Pregnancy, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute. The report was developed by a panel of obstetricians, pharmacologists, internists, allergists, and pulmonologists, who met over an 18-month period under the auspices of the NIH. Undertreatment of pregnant asthmatics, partially because of unfounded fears of adverse pharmacologic effects on the developing fetus, remains the major problem in the management of asthma during pregnancy in the United States. The four key components of asthma management during pregnancy are: 1) objective assessment of maternal lung function and fetal well-being, 2) avoidance or control of environmental precipitating factors, 3) pharmacologic therapy, and 4) patient education.

Original language	English (US)
Pages (from-to)	1036-1040
Number of pages	5
Journal	Obstetrics and gynecology
Volume	82
Issue number	6
State	Published - Dec 1993
Externally published	Yes

ASJC Scopus subject areas

Obstetrics and Gynecology

Cite this

@article{baac19f74f89486890039c5b6e9c07cf,

title = "Asthma in pregnancy",

abstract = "This manuscript is a summary of a comprehensive report dealing with asthma and pregnancy issued by the working group on Asthma and Pregnancy, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute. The report was developed by a panel of obstetricians, pharmacologists, internists, allergists, and pulmonologists, who met over an 18-month period under the auspices of the NIH. Undertreatment of pregnant asthmatics, partially because of unfounded fears of adverse pharmacologic effects on the developing fetus, remains the major problem in the management of asthma during pregnancy in the United States. The four key components of asthma management during pregnancy are: 1) objective assessment of maternal lung function and fetal well-being, 2) avoidance or control of environmental precipitating factors, 3) pharmacologic therapy, and 4) patient education.",

author = "Clark, {Steven L.} and Frederiksen, {Marilynn C.} and Jacobs, {Mark M.} and Ralph Kauffman and Luskin, {Allan T.} and Donald McNellis and Debra Myers and Nelson, {Harold S.} and Michael Schatz and Scialli, {Anthony R.} and Wise, {Robert A.} and Parker, {Sydney R.} and Taggert, {Virginia S.}",

year = "1993",

month = dec,

language = "English (US)",

volume = "82",

pages = "1036--1040",

journal = "Obstetrics and gynecology",

issn = "0029-7844",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Asthma in pregnancy

AU - Clark, Steven L.

AU - Frederiksen, Marilynn C.

AU - Jacobs, Mark M.

AU - Kauffman, Ralph

AU - Luskin, Allan T.

AU - McNellis, Donald

AU - Myers, Debra

AU - Nelson, Harold S.

AU - Schatz, Michael

AU - Scialli, Anthony R.

AU - Wise, Robert A.

AU - Parker, Sydney R.

AU - Taggert, Virginia S.

PY - 1993/12

Y1 - 1993/12

N2 - This manuscript is a summary of a comprehensive report dealing with asthma and pregnancy issued by the working group on Asthma and Pregnancy, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute. The report was developed by a panel of obstetricians, pharmacologists, internists, allergists, and pulmonologists, who met over an 18-month period under the auspices of the NIH. Undertreatment of pregnant asthmatics, partially because of unfounded fears of adverse pharmacologic effects on the developing fetus, remains the major problem in the management of asthma during pregnancy in the United States. The four key components of asthma management during pregnancy are: 1) objective assessment of maternal lung function and fetal well-being, 2) avoidance or control of environmental precipitating factors, 3) pharmacologic therapy, and 4) patient education.

AB - This manuscript is a summary of a comprehensive report dealing with asthma and pregnancy issued by the working group on Asthma and Pregnancy, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute. The report was developed by a panel of obstetricians, pharmacologists, internists, allergists, and pulmonologists, who met over an 18-month period under the auspices of the NIH. Undertreatment of pregnant asthmatics, partially because of unfounded fears of adverse pharmacologic effects on the developing fetus, remains the major problem in the management of asthma during pregnancy in the United States. The four key components of asthma management during pregnancy are: 1) objective assessment of maternal lung function and fetal well-being, 2) avoidance or control of environmental precipitating factors, 3) pharmacologic therapy, and 4) patient education.

UR - http://www.scopus.com/inward/record.url?scp=0027897599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027897599&partnerID=8YFLogxK

M3 - Article

C2 - 8233255

AN - SCOPUS:0027897599

SN - 0029-7844

VL - 82

SP - 1036

EP - 1040

JO - Obstetrics and gynecology

JF - Obstetrics and gynecology

IS - 6

ER -

Asthma in pregnancy

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this